• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Meeting the ADA Standards of Care

Meeting the ADA Standards of Care

9781580403382
300.45 zł
285.43 zł Save 15.02 zł Tax included
Lowest price within 30 days before promotion: 285.43 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Protocols to improve diabetes care in your hospital ward, clinic, or office

This book is an effective guide to improve the metrics (glycemic, lipid, blood pressure) of diabetes care. Using an algorithmic approach, you can improve patient outcomes. Dr. Davidson provides documentation and evidenced-based reasons to meet the glycemic, lipid, and blood pressure goals of the American Diabetes Association and background information for the drugs used to meet those outcome goals. In addition, based on the patients response, the book describes what therapeutic changes need to be made to provide the most efficient and effective care for patients.

  • This book provides specific protocols that have been shown to be clinically effective in markedly improving outcomes in people with diabetes.
  • Author Mayer Davidson, M.D., is a well-known and respected researcher and an expert in clinical endocrinology. He is a Professor of Medicine at the UCLA School of Medicine and a Principal Investigator at the Clinical Center for Research Excellence at the Charles Drew University of Medicine and Science (Los Angeles).

Topics include::
Laying the Groundwork (General Background, Glycemia, Lipids, Renal Evaluation, Hypertension, Aspirin, Smoking Cessation, Rationale for Algorithms); Evidence-Based Principles of Dietary Therapy; Glycemia (Goals of Therapy, Principles of Treatment, Non-Insulin Drugs, Metformin, Sulfonylurea Agents and Glinides, Thiazolidinediones; Incretins--Background, Incretin Analogs (Exenatide), Dipeptidyl Peptidase Inhibitors (Sitagliptin), Alpha-Glucosidase Inhibitors, Markedly Symptomatic Type 2 Diabetic Patients. Pramlintide, Self Monitoring of Blood Glucose, Insulin, General Approach, Bedtime Insulin / Daytime Oral Antidiabetes Drugs, Multiple Injections, Premixed Insulins, Delayed Response to NPH Insulin, Correction Doses, Glycemia Algorithm); . Dyslipidemia (Goals of Therapy, Principles of Treatment, Adverse Events, Medications, Dyslipidemia Algorithm); Hypertension, Background (Aldosterone Receptor Antagonists, Alpha-Adrenergic Receptor Atagonists, Alpha-Adrenergic Receptor Agonists, Angiotensin Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, Beta-Adrenergic Receptor, Antagonists, Calcium Channel Antagonists, Renin Inhibitors, Thiazide and Loop Diuretics, Vasodilators (Direct), Hypertension Algorithm)

Product Details
49678
9781580403382
9781580403382

Data sheet

Publication date
2010
Issue number
1
Cover
hard cover
Pages count
160
Dimensions (mm)
160 x 236
  • Chapter 1. Laying the Groundwork (General Background, Glycemia, Lipids, Renal Evaluation, Hypertension, Aspirin, Smoking Cessation, Rationale for Algorithms); Chapter 2. Evidence-Based Principles of Dietary Therapy; Chapter 3. Glycemia (Goals of Therapy, Principles of Treatment, Non-Insulin Drugs, Metformin, Sulfonylurea Agents and Glinides, Thiazolidinediones; Incretins – Background, Incretin Analogs (Exenatide), Dipeptidyl Peptidase Inhibitors (Sitagliptin), Alpha-Glucosidase Inhibitors, Markedly Symptomatic Type 2 Diabetic Patients. Pramlintide, Self Monitoring of Blood Glucose, Insulin, General Approach, Bedtime Insulin / Daytime Oral Antidiabetes Drugs, Multiple Injections, Premixed Insulins, Delayed Response to NPH Insulin, Correction Doses, Glycemia Algorithm)Chapter 4. Dyslipidemia (Goals of Therapy, Principles of Treatment, Adverse Events, Medications, Dyslipidemia Algorithm); Chapter 5. Hypertension, Background (Aldosterone Receptor Antagonists, Alpha-Adrenergic Receptor Atagonists, Alpha-Adrenergic Receptor Agonists, Angiotensin Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, Beta-Adrenergic Receptor, Antagonists, Calcium Channel Antagonists, Renin Inhibitors, Thiazide and Loop Diuretics, Vasodilators (Direct), Hypertension Algorithm)
Comments (0)